TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15261317

Group type: COMPARATOR
Intervention: nitroglycerin + normal saline (NS) i.v.
Number of subjects: 60

Group type: COMPARATOR
Intervention: nitroglycerin + ephedrine 0.1 mg/kg i.v.
Number of subjects: 60

Group type: COMPARATOR
Intervention: nitroglycerin + ephedrine 0.15 mg/kg i.v.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: trimethaphan + NS i.v.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: trimethaphan + ephedrine 0.1 mg/kg i.v.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: trimethaphan + ephedrine 0.15 mg/kg i.v.
Number of subjects: 60
Study: 10831810

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty
Number of subjects: 0
Study: 9083303

Group type: EXPERIMENTAL
Intervention: Dilute vasopressin solution (0.05 U/mL)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 52
Study: 1583417

Group type: EXPERIMENTAL
Intervention: Methylphenidate (optimal dose for 6 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (1 week without medication)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Methylphenidate (return to medication after placebo)
Number of subjects: 42
Study: 3159547

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) 50 mg/month
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) 100 mg/month
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA) 200 mg/month
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Testosterone cypionate (TC) 250 mg/month
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Post-discontinuation of DMPA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DMPA administration
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: DMPA withdrawal
Number of subjects: 30
Study: 30938101

Group type: EXPERIMENTAL
Intervention: PEAK PlasmaBlade
Number of subjects: 24

Group type: COMPARATOR
Intervention: Monopolar electrosurgery
Number of subjects: 24
Study: 30389035

Group type: EXPERIMENTAL
Intervention: 16K group (busulfan area under the curve of 16,000 mumol/min)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 20K group (busulfan area under the curve of 20,000 mumol/min)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 20K group
Number of subjects: 98
Study: 29043412

Group type: EXPERIMENTAL
Intervention: Etirinotecan pegol (EP) 145 mg/m2 Q21d
Number of subjects: 83

Group type: COMPARATOR
Intervention: Irinotecan 350 mg/m2 Q21d
Number of subjects: 83
Study: 25391324

Group type: EXPERIMENTAL
Intervention: Bridge exercises with a sling and micro vibrations (therapy group)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Bridge exercises with a sling without vibrations (control group)
Number of subjects: 32
Study: 23279860

Group type: EXPERIMENTAL
Intervention: Hygiene intervention (training mothers for 4 weeks on control point conditions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 60
Study: 21563962

Group type: EXPERIMENTAL
Intervention: 1250 mg of Neuravena®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2500 mg of Neuravena®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18486257

Group type: EXPERIMENTAL
Intervention: Increased basal/total daily insulin ratio (B/TD ratio) from about 0.35 to about 0.46+/‐0.12 without change of total insulin daily dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients whose B/TD ratio was not changed
Number of subjects: 0
Study: 16141377

Group type: EXPERIMENTAL
Intervention: High-fat diet (HFD) followed by carbohydrate loading (CHO)
Number of subjects: 8

Group type: COMPARATOR
Intervention: High-carbohydrate diet (HCD) followed by CHO
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-fat diet (HFD) followed by CHO
Number of subjects: 8
Study: 12937241

Group type: EXPERIMENTAL
Intervention: Pre-emptive oral ganciclovir therapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional deferred treatment (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 10636615

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 34

Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 34

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 34
Study: 9250252

Group type: EXPERIMENTAL
Intervention: Inhaled furosemide 20 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Normal saline (placebo-control)
Number of subjects: 37
Study: 8330089

Group type: EXPERIMENTAL
Intervention: Honey impregnated gauze
Number of subjects: 92

Group type: COMPARATOR
Intervention: OpSite (Control)
Number of subjects: 92
Study: 3735283

Group type: EXPERIMENTAL
Intervention: Subacromial injection of 40 mg of triamcinalone acetonide
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral indomethacin, 100 mg/day
Number of subjects: 40
Study: 29020193

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 2677
Study: 26602006

Group type: EXPERIMENTAL
Intervention: miniaturized CPB (mCPB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: conventional CPB (cCPB)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both mCPB and cCPB
Number of subjects: 26
Study: 24809878

Group type: EXPERIMENTAL
Intervention: adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 23529570

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (up to 10 mg/day)
Number of subjects: 814

Group type: COMPARATOR
Intervention: Glipizide (up to 20 mg/day)
Number of subjects: 814

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 814

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 814
Study: 20722686

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet plus exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical activity energy expenditure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mean energy intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mean total energy expenditure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Change in fructosamine level
Number of subjects: 0
Study: 18835885

Group type: EXPERIMENTAL
Intervention: Airway Scope
Number of subjects: 48

Group type: COMPARATOR
Intervention: gum elastic bougie with Macintosh laryngoscope
Number of subjects: 48
Study: 16631122

Group type: EXPERIMENTAL
Intervention: A1555G mutation carriers (deaf patients)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: A1555G mutation carriers (hearing carriers)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (sporadic cases)
Number of subjects: 54
Study: 14633083

Group type: EXPERIMENTAL
Intervention: Naftopidil (Naf)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Tamsulosin hydrochloride (Tam)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Naftopidil (Naf) and Tamsulosin hydrochloride (Tam)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Naf-to-Tam and Tam-to-Naf crossover groups
Number of subjects: 96
Study: 10965198

Group type: EXPERIMENTAL
Intervention: CAP (cyclophosphamide, pirarubicin and cisplatin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EP (etoposide and cisplatin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative CA125 levels <35 IU/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative CA125 levels >=35 IU/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with pelvic lymph node metastasis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients without pelvic lymph node metastasis
Number of subjects: 0
Study: 9599973

Group type: EXPERIMENTAL
Intervention: Psychiatric patients (schizophrenia)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 63
Study: 2532986

Group type: EXPERIMENTAL
Intervention: 5% benzoyl peroxide and 2% miconazole
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5% benzoyl peroxide alone
Number of subjects: 30
Study: 744492

Group type: EXPERIMENTAL
Intervention: Pomeroy's Kroener's or a combination of both surgical procedures
Number of subjects: 100
Study: 31564259

Group type: EXPERIMENTAL
Intervention: PECS block
Number of subjects: 120

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 120
Study: 28698243

Group type: EXPERIMENTAL
Intervention: De qi group (n=43) - deep needling at SP6 with manipulation using thick needles
Number of subjects: 88

Group type: COMPARATOR
Intervention: No de qi group (n=45) - shallow needling with no manipulation using thin needles
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Actual de qi sensation (n=68, regardless of group allocation)
Number of subjects: 88
Study: 25956202

Group type: EXPERIMENTAL
Intervention: Kneeling chair
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual flat chair
Number of subjects: 20
Study: 24284086

Group type: EXPERIMENTAL
Intervention: Oral 5-aminolevulinic acid (5-ALA)
Number of subjects: 90
Study: 21176727

Group type: EXPERIMENTAL
Intervention: Oral administration of roflumilast (ROF) 500 µg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous administration of roflumilast (ROF) 150 µg
Number of subjects: 12
Study: 18637718

Group type: EXPERIMENTAL
Intervention: 10% citric acid solution
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl) solution
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 810‐nm laser energy via a 200‐microm optic fiber at 2.5 W power in pulsed mode for 5 sec
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: NaOCl, followed by laser, then citric acid, followed by laser, then NaOCl and laser
Number of subjects: 116
Study: 16556612

Group type: EXPERIMENTAL
Intervention: Micronutrients (including zinc)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Micronutrients (including zinc and LAB)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 12970832

Group type: EXPERIMENTAL
Intervention: Evidence-based practice in stroke rehabilitation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Research knowledge transfer
Number of subjects: 0
Study: 10928228

Group type: EXPERIMENTAL
Intervention: Direct measurement of total hip BMD
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Calculated total hip BMD using formula: Total hip BMD = 0.48 x Neck BMD + 0.62 x Trochanteric BMD + 0.03
Number of subjects: 46
Study: 9295593

Group type: EXPERIMENTAL
Intervention: Neoral (converted from Sandimmune on a 1:1 dosing basis)
Number of subjects: 141
Study: 8316578

Group type: EXPERIMENTAL
Intervention: Fugl-Meyer assessment
Number of subjects: 12
Study: 2937707

Group type: EXPERIMENTAL
Intervention: Prednisolone therapy
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Withdrawal of prednisolone
Number of subjects: 10
Study: 31108930

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 54

Group type: COMPARATOR
Intervention: Self-Directed Intervention (SDI)
Number of subjects: 54
Study: 30167655

Group type: EXPERIMENTAL
Intervention: Modified Mindfulness-Based Stress Reduction (MBSR) training, weekly 2-hour classes and 20 minutes of daily home practice over 8 weeks.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Active control group (details not specified).
Number of subjects: 21
Study: 27576192

Group type: EXPERIMENTAL
Intervention: Multimodal rehabilitation program + Denneroll cervical traction device
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multimodal rehabilitation program
Number of subjects: 60
Study: 24773171

Group type: EXPERIMENTAL
Intervention: Sublingual allergen immunotherapy (SLIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22147287

Group type: EXPERIMENTAL
Intervention: Domperidone (10 mg three times a day for 10 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg three times a day for 10 days)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 80

Group type: COMPARATOR
Intervention: Metoclopramide (follow-on prescription)
Number of subjects: 80
Study: 20653798

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination therapy (polypill) with aspirin 81 mg, enalapril 2.5 mg, atorvastatin 20 mg, and hydrochlorothiazide 12.5 mg
Number of subjects: 475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 475
Study: 18411606

Group type: EXPERIMENTAL
Intervention: Local adrenaline administration into the surgical field before wound closure
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no local adrenaline)
Number of subjects: 121
Study: 15794389

Group type: EXPERIMENTAL
Intervention: Hydrolytic enzymes (HE)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 12174064

Group type: EXPERIMENTAL
Intervention: 532 nm Q‐switched Nd:YAG laser
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 585 nm FLPDL
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 532 nm variable pulse Nd:YAG laser
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (untreated segment)
Number of subjects: 6
Study: 10630854

Group type: EXPERIMENTAL
Intervention: Early tangential excision and skin grafting
Number of subjects: 50

Group type: COMPARATOR
Intervention: Honey dressing
Number of subjects: 50
Study: 8605133

Group type: EXPERIMENTAL
Intervention: Oestradiol vaginal ring
Number of subjects: 194

Group type: COMPARATOR
Intervention: Conjugated equine oestrogen vaginal cream
Number of subjects: 194
Study: 1524045

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 240 mg/day orally for at least 2 months
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 6388425

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (600 mg daily)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 31169066

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Transcutaneous acupoint electrical stimulation (TAES)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study: 29052225

Group type: EXPERIMENTAL
Intervention: Peripheral nerve blocks with pre‐emptive ibuprofen and paracetamol
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Peripheral nerve blocks
Number of subjects: 13
Study: 27207749

Group type: EXPERIMENTAL
Intervention: Stop Delirium! intervention (16-month enhanced educational package)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Usual care (control homes)
Number of subjects: 215
Study: 24858921

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (RT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 140
Study: 24707449

Group type: EXPERIMENTAL
Intervention: Upper-body resistance training with self-efficacy enhancement (UBR + SE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Upper-body resistance training and health education (UBR + HE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combined UBR + SE and UBR + HE
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combined UBR groups
Number of subjects: 64

Group type: COMPARATOR
Intervention: Gentle chair exercises and health education (CE + HE)
Number of subjects: 64
Study: 20179751

Group type: EXPERIMENTAL
Intervention: Standard 6 month anti-tuberculosis (TB) therapy
Number of subjects: 38
Study: 18625184

Group type: EXPERIMENTAL
Intervention: Propensity score methodology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized control trials
Number of subjects: 0
Study: 16052109

Group type: EXPERIMENTAL
Intervention: Entropy group (anesthesia with entropy values shown)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group (anesthesia with entropy values not shown)
Number of subjects: 368
Study: 11790638

Group type: EXPERIMENTAL
Intervention: Transdermal xanomeline, an M1‐selective cholinergic agonist, administered for 4 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, administered for 4 months.
Number of subjects: 0
Study: 10618939

Group type: EXPERIMENTAL
Intervention: Rectal paracetamol 1.3 g
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Diclofenac 50 mg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Rectal paracetamol and diclofenac
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 72
Study: 8543846

Group type: EXPERIMENTAL
Intervention: hMG preparation containing a 3:1 ratio of FSH/LH (Group A)
Number of subjects: 84

Group type: COMPARATOR
Intervention: hMG at an FSH/LH 1:1 ratio (Group B)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Pure FSH (Group C)
Number of subjects: 84
Study: 1935730

Group type: EXPERIMENTAL
Intervention: Oxamniquine 750 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oxamniquine 1000 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oxamniquine 1250 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Oxamniquine (all doses)
Number of subjects: 5
Study: 6775094

Group type: EXPERIMENTAL
Intervention: medroxyprogesterone acetate, 20 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 30422368

Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg once daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Esomeprazole (10 mg or 20 mg)
Number of subjects: 50
Study: 28475373

Group type: EXPERIMENTAL
Intervention: Lurasidone 40 mg/day
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/day
Number of subjects: 326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study: 26399101

Group type: EXPERIMENTAL
Intervention: Group A (15-20 mm tibial stump)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Group B (5-10 mm tibial stump)
Number of subjects: 42

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 42
Study: 24502859

Group type: EXPERIMENTAL
Intervention: Aripiprazole (2-15 mg/d)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 85
Study: 22148961

Group type: EXPERIMENTAL
Intervention: Whey Protein Ingestion (WPI)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Resistance Exercise
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Resistance Exercise and WPI
Number of subjects: 31
Study: 20829497

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (sucrose)
Number of subjects: 12
Study: 17507833

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (CEE) 0.625 mg/d
Number of subjects: 27

Group type: COMPARATOR
Intervention: Transdermal estradiol (TD E2) 0.05 mg/d
Number of subjects: 27
Study: 15843081

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 12197589

Group type: EXPERIMENTAL
Intervention: Family-based intervention (tailoring two family members, one adult and one child)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Individual-based intervention (tailoring one family member, one adult or one child)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Tailored fat feedback letters (both conditions)
Number of subjects: 180
Study: 9654760

Group type: EXPERIMENTAL
Intervention: Dysphoric targets expected to be nondysphoric
Number of subjects: 240

Group type: COMPARATOR
Intervention: Nondysphoric targets
Number of subjects: 240
Study: 8270459

Group type: EXPERIMENTAL
Intervention: Fast neutron irradiation (2040 ncGy)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Photon irradiation (7000-7020 cGy)
Number of subjects: 172
Study: 2564725

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 45
Study: 29894865

Group type: EXPERIMENTAL
Intervention: m-health self-management intervention delivered via smartphone apps
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 290
Study: 27421281

Group type: EXPERIMENTAL
Intervention: Low Back Pain Rating Scale assessment at 1.5 years follow-up
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low Back Pain Rating Scale assessment at 12 years follow-up
Number of subjects: 120
Study: 25659979

Group type: COMPARATOR
Intervention: One meal served on a non-HD day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: One meal served during HD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Two meals served during and after HD
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Glucose-insulin infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: No infusion
Number of subjects: 12
Study: 24120179

Group type: EXPERIMENTAL
Intervention: Probiotic cheese (Lactobacillus plantarum TENSIA), 1500 kcal/d diet for 3 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control cheese, 1500 kcal/d diet for 3 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Probiotic cheese (Lactobacillus plantarum TENSIA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control cheese
Number of subjects: 40
Study: 20419730

Group type: EXPERIMENTAL
Intervention: Group intervention at school
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Individual treatment at a mental health clinic
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 195
Study: 18701831

Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (STPP) (1 session/week)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fluoxetine treatment (20‐40 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Both treatments (STPP and fluoxetine)
Number of subjects: 51
Study: 17085376

Group type: EXPERIMENTAL
Intervention: HRT with 1 mg/day micronized 17beta-estradiol and 10 mg/day dydrogesterone for 14 days of each 28-day cycle
Number of subjects: 66

Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 66